In the majority of T-SCLC patients, p53 and RB1 inactivation is observed in the pre-transformed NSCLC, and combined loss of both genes is currently the strongest predictor of SCLC transformation in EGFR-mutant NSCLC patients [12,13,43,55]. Here, TP53 is linked to non-small cell lung carcinoma.